Kebudi et al., also studied the relevance of CD44 levels in serum (measured by ELISA), in the context of pediatric sarcomas (18 rhabdomyosarcomas, 22 Ewing sarcoma, and 15 osteosarcomas). This evidence concerns the gene CD44 and rhabdomyosarcoma.